Skip to main content

Weight Management News

FDA Approves Zepbound (tirzepatide) as the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity

INDIANAPOLIS, Dec. 20, 2024 /PRNewswire/ – Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound (tirzepatide) as the first and only...

Ozempic Curbs Kidney Disease in Obese People Without Diabetes

MONDAY, Oct. 28, 2024 – The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide – the active agent in Ozempic and Wegovy – had...

FDA Approves Wegovy (semaglutide) to Treat Adults with Obesity

PLAINSBORO, N.J., June 4, 2021 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the new drug application (NDA) for Wegovy™ (semaglutide) injec...

KVK Tech Announces FDA-Approval of Lomaira (phentermine hydrochloride USP) for Weight Reduction

NEWTOWN, Pa., Sept. 20, 2016 /PRNewswire/ – KVK Tech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Lomaira (phentermine hydrochloride USP) 8 mg tablets CIV, a...

Ask a question

To post your own question to our community, sign in or create an account.